NRx Pharmaceuticals announces initiation of Phase 2b trial of BriLife vaccine for Covid-19
Preclinical and early human data indicate BriLife may confer enhanced immunity against Delta variant
Preclinical and early human data indicate BriLife may confer enhanced immunity against Delta variant
By 2022, 150,000 primary health care centres would be in place in rural as well as urban areas
The government has recently enhanced the incentive granted to storeowners from existing Rs. 2.50 lakh to Rs. 5.00 lakh given at the rate of 15% of monthly purchases made, subject to a ceiling of Rs. 15,000 per month
Filing for WHO Emergency Use Authorisation this month
Single booster dose at 6 months of NVX-CoV2373 increased wild-type neutralizing antibodies more than 4-fold versus primary vaccination series
This work has been published in the journal ‘ACS applied materials and interface’
Sickle Cell Disease Support Corner developed to create a database of individuals with sickle cell disease
The transaction is expected to close in the Q4FY22
CDSCO to fast-track trials and approval for COVID19 vaccine
Centre at Sree Chitra Tirunal Institute for Medical Sciences and Technology
Subscribe To Our Newsletter & Stay Updated